D

Dare Bioscience
D

DARE

3.34000
USD
0.15
(4.70%)
Market Closed
Volume
522
EPS
-0
Div Yield
-
P/E
-6
Market Cap
29,059,299
OverviewSignalsIdeasNews
Related Instruments
    A
    APRN
    0.000
    (0.00%)
    12.995 USD
    A
    ATHE
    -0.03000
    (-2.59%)
    1.13000 USD
    C
    CAPR
    0.100
    (0.54%)
    18.620 USD
    C
    CCS
    -1.570
    (-1.79%)
    86.110 USD
    M
    MRSN
    -0.31000
    (-12.30%)
    2.21000 USD
    P
    PRQR
    -0.13000
    (-3.28%)
    3.83000 USD
    T
    TRVN
    -2.02000
    (-44.99%)
    2.47000 USD
    T
    TTOO
    -0.00300
    (-0.57%)
    0.52000 USD
    More
News

Title: Dare Bioscience Inc.

Sector: Healthcare
Industry: Biotechnology
Dare Bioscience Inc is a biopharmaceutical company committed to advancing innovative products for women's health. The company identifies, develops and brings to market a diverse portfolio of differentiated therapies that prioritize women'shealth and well-being, expand treatment options, and improve outcomes, in the areas of contraception, fertility, and vaginal and sexual health. The company's first product, XACIATO is a single-dose vaginal gel prescription product for the treatment of bacterial vaginosis in females 12 years of age and older. The company's portfolio includes two product candidates in advanced clinical development namely, Ovaprene and Sildenafil Cream. It has one operating segment, women's health.